Neogen ( (NEOG) ) has released its Q3 earnings. Here is a breakdown of the information Neogen presented to its investors.
Neogen Corporation, a leader in food safety, livestock, and pet health markets, has a global presence in over 140 countries, providing comprehensive solutions through science and technology. In its third-quarter 2025 earnings report, Neogen announced a revenue of $221.0 million, with a net loss of $11.0 million, while adjusted net income stood at $20.9 million. The company highlighted progress in its Food Safety segment despite challenges in sample collection revenue and global trade uncertainties.
Key financial metrics revealed a 3.4% decrease in total revenue compared to the previous year, with core revenue showing a slight increase of 0.2%. The Food Safety segment experienced a 3.2% revenue decline, while the Animal Safety segment saw a 4.0% decrease. Adjusted EBITDA was reported at $48.5 million, reflecting a margin of 22.0%. The company faced challenges from foreign currency impacts and discontinued product lines, which contributed to the revenue decline.
Despite the financial setbacks, Neogen made significant strides in its Petrifilm production and maintained a strong performance in pathogen detection products within its Food Safety segment. The company also noted a decline in its Genomics business, attributed to restructuring activities. Neogen’s liquidity position included $127.7 million in cash and $900.0 million in non-current debt.
Looking ahead, Neogen has updated its full-year guidance, anticipating revenue of approximately $895 million and adjusted EBITDA of $195 million. The company remains focused on executing its strategic initiatives and managing through current economic uncertainties, with optimism about its long-term growth potential.